Palantir: A Powerful Story Wrapped in a Dangerous Valuation

By Mickelberry Capital

Some companies don’t trade on numbers.
They trade on narratives.

Palantir is one of them.

At Mickelberry Capital, our negative sentiment toward Palantir has very little to do with its technology — and almost everything to do with valuation, incentives, and expectations that have outrun reality.

This is not a dismissal of what Palantir has built.
It’s a warning about what the market is assuming will happen next.


The Palantir Problem Isn’t the Product — It’s the Price

Palantir operates in a space investors love:

  • Data analytics
  • AI-driven decision systems
  • Government contracts
  • Enterprise software

On the surface, it checks every “future-facing” box.

But markets don’t reward good ideas — they reward cash flow at the right price.

And Palantir’s valuation demands perfection.

At current levels, the stock implies:

  • Sustained high growth
  • Expanding margins
  • Flawless execution
  • Long-term dominance in a competitive field

That’s a dangerous stack of assumptions.


Stock-Based Compensation: The Silent Tax

One of our biggest concerns with Palantir is stock-based compensation (SBC).

Yes, SBC has improved relative to revenue.
No, that does not make it harmless.

Here’s why it matters:

  • SBC dilutes shareholders quietly
  • It inflates “adjusted” profitability
  • It rewards insiders regardless of stock performance
  • It masks the true cost of labor

A company can show accounting profits while still transferring value away from shareholders.

When valuation is stretched, dilution becomes even more dangerous.


Profitability vs. Quality of Earnings

Palantir is technically profitable — but the quality of those earnings deserves scrutiny.

Key questions we ask:

  • How much profit exists without SBC add-backs?
  • How dependent is growth on government spending cycles?
  • How sticky are enterprise customers without long-term contracts?
  • What happens in a tighter budget environment?

Profitability is not binary.
There is durable profit — and there is fragile profit.

We believe Palantir currently sits closer to the latter.


Government Contracts Are Not a Moat — They’re a Constraint

Palantir’s deep ties to government and defense are often framed as a competitive advantage.

We see the other side:

  • Long sales cycles
  • Political budget risk
  • Regulatory scrutiny
  • Limited pricing flexibility
  • Dependency on institutional decision-makers

Government work can stabilize revenue — but it also caps upside and slows innovation cycles.

That’s not what premium multiples are built on.


AI Hype vs. AI Monetization

Palantir is increasingly lumped into the “AI winners” category.

But here’s the uncomfortable truth:

AI capability does not equal AI monetization.

Investors are pricing Palantir as if:

  • AI demand will accelerate uncontested
  • Customers will scale usage aggressively
  • Pricing power will increase
  • Margins will expand meaningfully

The gap between AI excitement and AI dollars remains wide.

We’ve seen this before.


Market Psychology: Why Palantir Keeps Getting a Pass

Palantir benefits from:

  • Strong founder narratives
  • Retail investor enthusiasm
  • Defense-sector credibility
  • AI adjacency
  • “Mission-driven” branding

These factors create emotional attachment.

Markets forgive valuation sins when stories feel important.

But eventually, price meets performance.


How This Fits Our Broader View at Mickelberry Capital

Our skepticism toward Palantir aligns with how we evaluate risk:

  • We avoid paying premium prices for uncertain cash flows
  • We are cautious with narrative-driven valuations
  • We respect dilution as a real cost
  • We prefer boring, durable, cash-generating businesses

A great company can still be a bad investment.

Palantir, at current valuations, fits that category for us.


Final Thought: Discipline Beats Excitement

Palantir may continue to rise.
Momentum can persist longer than fundamentals.

But investing isn’t about chasing what feels important — it’s about owning what’s priced correctly.

At Mickelberry Capital, we would rather miss upside than overpay for hope.

Because hope doesn’t compound.
Cash flow does.


Do Your Own Research

Nothing in this post is financial advice.
Every investor must evaluate risk independently.

Leave a comment